Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 1
2008 2
2009 1
2010 2
2012 1
2013 1
2014 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
How to predict a high rate of inappropriateness for upper endoscopy in an endoscopic centre?
Buri L, Bersani G, Hassan C, Anti M, Bianco MA, Cipolletta L, Di Giulio E, Di Matteo G, Familiari L, Ficano L, Loriga P, Morini S, Pietropaolo V, Zambelli A, Grossi E, Intraligi M, Tessari F, Buscema M; SIED Appropriateness Working Group. Buri L, et al. Dig Liver Dis. 2010 Sep;42(9):624-8. doi: 10.1016/j.dld.2010.02.012. Epub 2010 Mar 21. Dig Liver Dis. 2010. PMID: 20308024
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis.
Pressiani T, Boni C, Rimassa L, Labianca R, Fagiuoli S, Salvagni S, Ferrari D, Cortesi E, Porta C, Mucciarini C, Latini L, Carnaghi C, Banzi M, Fanello S, De Giorgio M, Lutman FR, Torzilli G, Tommasini MA, Ceriani R, Covini G, Tronconi MC, Giordano L, Locopo N, Naimo S, Santoro A. Pressiani T, et al. Ann Oncol. 2013 Feb;24(2):406-411. doi: 10.1093/annonc/mds343. Epub 2012 Oct 5. Ann Oncol. 2013. PMID: 23041587 Free article. Clinical Trial.
Appropriateness guidelines and predictive rules to select patients for upper endoscopy: a nationwide multicenter study.
Buri L, Hassan C, Bersani G, Anti M, Bianco MA, Cipolletta L, Di Giulio E, Di Matteo G, Familiari L, Ficano L, Loriga P, Morini S, Pietropaolo V, Zambelli A, Grossi E, Intraligi M, Buscema M; SIED Appropriateness Working Group. Buri L, et al. Am J Gastroenterol. 2010 Jun;105(6):1327-37. doi: 10.1038/ajg.2009.675. Epub 2009 Dec 22. Am J Gastroenterol. 2010. PMID: 20029414 Clinical Trial.
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes.
Cocconi G, Di Blasio B, Boni C, Bisagni G, Rondini E, Bella MA, Leonardi F, Savoldi L, Vallisneri C, Camisa R, Bruzzi P; Italian Oncology Group for Clinical Research (GOIRC), Parma, Italy. Cocconi G, et al. Ann Oncol. 2005 Sep;16(9):1469-76. doi: 10.1093/annonc/mdi278. Epub 2005 Jun 14. Ann Oncol. 2005. PMID: 15956038 Free article. Clinical Trial.